What does Sea Moss do?#
A leave-on serum with sea moss — Chondrus crispus, a red seaweed gathered on North Atlantic shores and also sold as Irish moss. Its extract holds water at the skin's surface and dries to a soft, light film, so skin looks and feels more hydrated.
Benefits
- Holds water at the surface, so skin feels more comfortable and looks less dry
- Dries down to a light, flexible film with a smooth, cushioned feel — the same gel-forming quality that makes it a thickener in foods and creams
- Gentle enough for morning and night, every day, with no easing-in period
- Rated safe as used in cosmetics by the independent safety review, with a long record of use in leave-on products
How it works
Sea moss is the red seaweed Chondrus crispus, harvested on North Atlantic coasts and long used as the source of carrageenan, the gel-forming thickener in foods and creams. Its extract does on skin what the whole plant does in a pot: it binds water. Applied in a serum it holds moisture at the surface and dries down to a thin, flexible film, so what it changes is how hydrated skin looks and feels. The molecules are large, so they are not expected to pass beyond the surface.
What to expect
Most people have no break-in phase, and nothing in its record describes one.
How to use Sea Moss#
Best time
Morning or evening — nothing in the record ties it to one end of the day, and it is not known to make skin more sensitive to daylight.
Where it goes
Most often in a serum or gel, after cleansing and before moisturiser. It also turns up in creams, sheet masks and hydrogel patches, where it goes wherever that product goes.
Where to apply
All over the face, including around the eyes — it has a long record of use in eye creams and patches.
How to apply
However the product is designed to be used — a thin layer is enough, since it works as a film on the surface. Daily is fine, and there is no easing-in period.
Alongside others
Nothing in the catalog is flagged against it, so there is no clash to plan around — and no published study supports recommending a particular pairing either.
What to expect
Most people have no break-in phase, and nothing in its record describes one.
What to look for
On a label the seaweed appears as Chondrus Crispus Extract or Powder, sometimes as Irish Moss Extract. Carrageenan — the thickener extracted from it — is listed under its own name and is a different entry: a product thickened with carrageenan is not a sea moss product. Sea moss powder is also the gel base of many hydrogel masks and eye patches, where it is doing the job of the gel rather than starring.
If it doesn't suit
If seaweed or algae products have upset your skin before, patch test on the inner arm first. If it stings, itches or brings up redness, rinse it off and stop using it.
Discontinue use if unexpected discomfort occurs.
The form you will see it in
Sea moss hydrating serum
- Where it goes
- Before moisturizer
Using Sea Moss with other ingredients
What not to use with Sea Moss
Nothing flagged. None of the ingredients this wiki covers needs to be kept apart from Sea Moss — check the label of anything not covered here.
Who should avoid Sea Moss?#
Six situations change whether Sea Moss suits your skin right now. Each one is either a reason to skip it, a reason to go slowly, or nothing to watch for.
- Maternity & Nursing
- No caution
- Fragile or Sensitive
- No caution
- Recent Facial or Laser
- No caution
- Prone to Redness
- No caution
- Dry or Itchy Patches
- No caution
- Recent Shave or Wax
- No caution
Cosmetic strength limits for Sea Moss where you live#
| Region | Most a cosmetic may contain | |
|---|---|---|
| No explicit cap | ||
The FDA restricts a short list of ingredients and sets no general strength ceiling on the rest. A figure marked "guidance, not law" is the Cosmetic Ingredient Review panel's recommendation. 21 CFR part 700, subpart B — Requirements for Specific Cosmetic Products (FDA) | ||
| No explicit cap | ||
One list does the work — Health Canada's Hotlist of prohibited and restricted cosmetic ingredients. | ||
| No explicit cap | ||
The Cosmetics Regulation's annexes, consolidated to 1 May 2026. A figure marked "guidance, not law" comes from the EU's cosmetic safety committee rather than from the annexes. | ||
| No explicit cap | ||
Great Britain kept the annexes as its own law and updates them only when it chooses; Northern Ireland follows the live EU Regulation, which is why some rows read differently for each. Regulation (EC) No 1223/2009 as it applies in Great Britain · Regulation (EC) No 1223/2009, Annexes II–VI | ||
| No explicit cap | ||
India writes its own standard, aligned to the European rules as they stood in 2012. Mandatory since 9 February 2026. IS 4707 (Part 2):2025 — restricted and prohibited cosmetic ingredients · IS 4707 (Part 3):2025 — preservatives · Cosmetics Rules, 2020, Ninth Schedule | ||
| No explicit cap | ||
ANVISA rewrote its restricted list in June 2026, and a companion act amended the prohibited list at the same time. RDC 1.029/2026 — restricted ingredients · RDC 529/2021 — prohibited ingredients, as amended by RDC 1.030/2026 · RDC 528/2021 — preservatives | ||
| No explicit cap | ||
Japan's cosmetics standard keeps drug ingredients out of cosmetics, so most of its figures sit in the ministry's list of the ones a cosmetic may still contain. Cosmetics Standards (化粧品基準), Ministry of Health, Labour and Welfare · Cosmetics Standards — the ministry's own English translation · Drug ingredients permitted in cosmetics — 2007 notification | ||
| No explicit cap | ||
One MFDS regulation carries both the prohibited list and the restricted list, in force 18 March 2026. Sunscreens and a few other categories are cleared product by product instead. Regulation on Safety Standards for Cosmetics (MFDS Notification 2026-19) · Regulation on the Review of Functional Cosmetics (MFDS Notification 2025-88) | ||
| No explicit cap | ||
Kenya's standard applies the EU annexes as they stand rather than copying them, so its ingredient limits are the EU's — including the 2024 additions. A figure marked "guidance, not law" sits outside the annexes and does not carry over. KS EAS 377-1, -2 and -3:2022 — cosmetics safety requirements, published by KEBS · Regulation (EC) No 1223/2009, Annexes II–VI | ||
| No explicit cap | ||
Namibia sets no ingredient limits at all. Its cosmetic rule is a single line requiring a product to be free of any harmful ingredient. Foodstuffs, Cosmetics and Disinfectants Ordinance 18 of 1979, and the regulations under it | ||
| No explicit cap | ||
Ukraine's own transposition of the EU annexes, as they stood before the 2024 additions, fully in force since 3 August 2026. A further revision is due on 1 February 2027. Technical Regulation on cosmetic products — Cabinet Resolution No. 65 of 20 January 2021 | ||
| No explicit cap | ||
Georgia has no cosmetics rulebook — its register of technical regulations carries no cosmetics entry — so only the general product-safety duty applies. | ||
| No explicit cap | ||
Australia writes no cosmetic ingredient list. A figure here is the point at which a substance becomes a medicine or a scheduled substance carrying Caution labelling, so its numbers sit well above other markets'. Poisons Standard — June 2026 · Therapeutic Goods (Excluded Goods) Determination 2018 | ||
| No explicit cap | ||
The Gulf standard points at the EU annexes as amended, so its ingredient limits are the EU's. A figure marked "guidance, not law" sits outside the annexes and does not carry over. GSO 1943:2024 — Cosmetic products: safety requirements (Gulf technical regulation) · Regulation (EC) No 1223/2009, Annexes II–VI | ||
| No explicit cap | ||
The Gulf standard points at the EU annexes as amended, so its ingredient limits are the EU's. A figure marked "guidance, not law" sits outside the annexes and does not carry over. GSO 1943:2024 — Cosmetic products: safety requirements (Gulf technical regulation) · Regulation (EC) No 1223/2009, Annexes II–VI | ||
| No explicit cap | ||
Hong Kong writes no cosmetics rulebook. Its Poisons List (Cap. 138A, Schedule 10) decides which substances may be sold only as medicines, and general safety is judged case by case against whichever overseas standard the enforcer considers reasonable. Pharmacy and Poisons Regulations (Cap. 138A), Schedule 10 — the poisons list · Pharmacy and Poisons Board — Guidance Notes on classifying pharmaceutical products, April 2026 | ||
| No explicit cap | ||
Singapore writes the ASEAN annexes into its own schedule, and its regulator tells companies to check the current ASEAN release as well — which is why a figure here can read "guidance, not law". Health Products (Cosmetic Products — ASEAN Cosmetic Directive) Regulations 2007, Third Schedule · ASEAN Cosmetic Directive annexes — release 2026-1, 22 June 2026 | ||
| No explicit cap | ||
Brunei carries the 2007 ASEAN annexes in its own schedule and has not updated them since, so it reads differently from Singapore on several ingredients. Medicines (Cosmetic Products) Regulations (Cap. 285 Rg 1), Schedule 1 — revised edition 2024 | ||
| No explicit cap | ||
Jordan's cosmetic rules defer to "the approved references" and name none of them, so there is no Jordanian figure to read. The only number in the instrument governs the ingredient list on the pack. JFDA instructions on cosmetics and pharmaceutical cosmetics, 2026 | ||
| No explicit cap | ||
Trinidad and Tobago has had the power to set cosmetic standards since 1960 and has never used it. The regulations made under the Act cover food and drugs, with no cosmetics part; what binds is the Act's general rule against selling a cosmetic that may injure the user. Food and Drugs Act, Chap. 30:01 · Food and Drugs Regulations | ||
No cosmetic regulator in the 20 markets above sets a maximum strength for sea moss. That is the state of the rules, not a signal to use more: how much goes into a product is the formulator's decision.
Open a market to see the rulebook its figure comes from. Those notes describe each market's own rules as we read them, current to August 24, 2026; the linked documents are the authority, and nothing here is legal advice.
Common questions about Sea Moss#
What is Sea Moss?
- The water-binding extract of a red seaweed better known as a food supplement — on skin it holds moisture at the surface and leaves a light, soft film, so skin looks and feels more hydrated.
What else is Sea Moss called?
- On a label you may see Chondrus crispus extract, Chondrus crispus powder, Irish moss extract, Sea moss extract and Hydrolyzed Chondrus crispus extract.
When should you apply Sea Moss?
- Morning or evening. Morning or evening — nothing in the record ties it to one end of the day, and it is not known to make skin more sensitive to daylight.
How often can you use Sea Moss?
- Daily.
Where do you apply Sea Moss?
- All over the face. Keep it away from your eyes and lips.
Can you use Sea Moss around the eyes?
- Yes. Sea Moss goes all over the face, the skin around the eyes included — keep it out of your eyes and off your lips.
Does Sea Moss make skin more sensitive to the sun?
- No. Sea Moss is not flagged as increasing sun sensitivity.
What should you not use with Sea Moss?
- Nothing flagged. None of the ingredients this wiki covers needs to be kept apart from Sea Moss — check the label of anything not covered here.
Is there a cosmetic limit for Sea Moss?
- No. No cosmetic regulator in the United States, Canada, the European Union or Great Britain sets a maximum strength for it. That is a limit on the rules, not a signal to use more.
Related ingredients#
How we check this#
Everything on this page traces to the sources listed below — regulators' own publications and published studies. Where the evidence does not answer a question, it is left unanswered.
Some sources below are medical studies. This ingredient has been studied in conditions a doctor treats, and the record cited here includes findings that did not favour it. We use those studies for their safety and handling detail only. A cosmetic product is not a medicine and is not intended to treat, cure or prevent any condition.
Some sources below are the official product information for prescription medicines, cited for how they interact with this ingredient. We use them for their safety and handling detail only. A cosmetic product is not one of those medicines and is not intended to treat any condition.
Our review is AI-assisted and is not a named expert's opinion. Last reviewed September 10, 2026.
Think something here is out of date or wrong? Email us at wiki@skinintelligence.ai with your reasoning and where you read it. We read what people send, and we update the page when the sources support it.
Regulators and official bodies · 17
- S1Cosmetic Ingredient Review, Expert Panel for Cosmetic Ingredient Safety. Safety Assessment of Red Algae-Derived Ingredients as Used in Cosmetics. Final Report, released 27 September 2021 (Panel meeting 13–14 September 2021; prepared by Priya Cherian). — vault. Tier 1.
- S2Cosmetic Ingredient Review, CIR Expert Panel. Safety Assessment of Polysaccharide Gums as Used in Cosmetics. Final Report, released 22 October 2015. — vault. Tier 1.
- S3European Commission, CosIng. Ingredient: CHONDRUS CRISPUS EXTRACT (ref. 75010; CAS 244023-79-8; functions SKIN CONDITIONING, VISCOSITY CONTROLLING). — vault. Tier 1.
- S4European Commission, CosIng. Ingredient: CARRAGEENAN (ref. 88730; CAS 9000-07-1; EC 232-524-2). — vault. Tier 1.
- S5Commission Decision (EU) 2019/701 establishing a glossary of common ingredient names (CELEX 32019D0701) — entries CHONDRUS CRISPUS, CHONDRUS CRISPUS EXTRACT, CHONDRUS CRISPUS POWDER, HYDROLYZED CHONDRUS CRISPUS EXTRACT, CARRAGEENAN. Vault. Tier 1.
- S621 CFR § 182.7255 Chondrus extract (eCFR, current). — vault. Tier 1.
- S721 CFR § 172.620 Carrageenan (eCFR, current). — vault. Tier 1.
- S821 CFR Part 700 General and Subpart B Requirements for Specific Cosmetic Products (eCFR) — vault,. Tier 1 (silent on this material).
- S9Regulation (EC) No 1223/2009 on cosmetic products, consolidated text (CELEX 32009R1223), Annexes II and III — vault. Tier 1 (silent).
- S10Regulation (EC) No 1223/2009 as retained in UK law, Annex II and Annex III (legislation.gov.uk) — vault,,. Tier 1 (silent).
- S11Health Canada. Cosmetic Ingredient Hotlist (full list, captured 2026-09-01). — vault. Tier 1 (silent).
- S12EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS); Younes M, Aggett P, Aguilar F, Crebelli R, Filipič M, et al. Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives. EFSA Journal 2018;16(4):5238. doi:10.2903/j.efsa.2018.5238. PMID 32625873 / PMC7009739 — vault. Tier 1.
- S26UK SmPCs (emc) held in the vault and swept for "carrageenan / Chondrus / seaweed / algae" — all zero except Pradaxa: Roaccutane 10 mg () and 20 mg (), Isotretinoin 10 mg (), Tretinoin 10 mg (), Differin Cream () and Gel (), Aklief (), Epiduo (), Adawell (), Treclin (), Lymecycline (), Tetralysal (), Efracea (), Cefadroxil (), Ciprofloxacin (), Methotrexate (), Cisplatin (), Deximune (); Pradaxa 75 mg () lists carrageenan under section 6.1 excipients only. Tier 1.
- S2921 CFR Part 700, Subpart B — Requirements for Specific Cosmetic Products (eCFR, current). Tier 1.
- S30Regulation (EC) No 1223/2009 on cosmetic products, as assimilated in UK law — Annexes II, III, IV and V. Tier 1.
- S31Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives — EFSA Journal, 2018. PMID 32625873. Tier 1/2 (EU regulator opinion, food route).
- S32Aklief 50 microgram/g cream — Summary of Product Characteristics (trifarotene), emc. Tier 1.
Studies and references · 22
- S13κ-Carrageenan tetrasaccharide ameliorates particulate matter-induced defects in skin hydration of human keratinocytes cells and skin barrier disorders — Int J Biol Macromol 2025;301:140395, doi:10.1016/j.ijbiomac.2025.140395. PMID 39880261. Tier 2. Degraded material — an enzymatic digestion product of κ-carrageenan, not the label ingredient; cited only where labelled..
- S14Premarathna AD, Ahmed TAE, Rjabovs V, Hammami R, Critchley AT, Tuvikene R, Hincke MT. Immunomodulation by xylan and carrageenan-type polysaccharides from red seaweeds: Anti-inflammatory, wound healing, cytoprotective, and anticoagulant activities. Int J Biol Macromol 2024;260(Pt 1):129433. doi:10.1016/j.ijbiomac.2024.129433. PMID 38232891 — vault. Tier 2 (in vitro).
- S15López-Hortas L, Torres MD, Falqué E, Domínguez H. Physicochemical Evaluation of Personal Care Products Developed with Chondrus crispus Fractions Processed by Ecofriendly Methodologies. Mar Drugs 2022;20(11):695. doi:10.3390/md20110695. PMID 36355018 / PMC9692426 — vault. Tier 2 (rheology only; no skin endpoint).
- S16Pangestuti R, Shin KH, Kim SK. Anti-Photoaging and Potential Skin Health Benefits of Seaweeds. Mar Drugs 2021;19(3):172. doi:10.3390/md19030172. PMID 33809936 / PMC8004118 — vault. Tier 2 (narrative review).
- S17Borsani B, De Santis R, Perico V, Penagini F, Pendezza E, Dilillo D, et al. The Role of Carrageenan in Inflammatory Bowel Diseases and Allergic Reactions: Where Do We Stand? Nutrients 2021;13(10):3402. doi:10.3390/nu13103402. PMID 34684400 / PMC8539934 — vault. Tier 2 (narrative review; oral/GI).
- S18Badilli U, Inal O. Current Approaches in Cosmeceuticals: Peptides, Biotics and Marine Biopolymers. Polymers 2025;17(6):798. doi:10.3390/polym17060798. PMID 40292641 / PMC11946782 — vault. Tier 2 (narrative review).
- S19Athukorala Y, Trang S, Kwok C, Yuan YV. Antiproliferative and Antioxidant Activities and Mycosporine-Like Amino Acid Profiles of Wild-Harvested and Cultivated Edible Canadian Marine Red Macroalgae. Molecules 2016;21(1):119. doi:10.3390/molecules21010119. PMID 26805798 / PMC6274348 — vault. Tier 2 (compositional/in vitro).
- S20Fernández-Romero JA, Abraham CJ, Rodriguez A, Kizima L, Jean-Pierre N, Menon R, et al. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrob Agents Chemother 2012. doi:10.1128/AAC.05461-11. PMID 22064530 / PMC3256046 — vault. Tier 2 (mucosal, formulation).
- S21Şatır H, Erkut TS, Çakır D, Gümüşderelioğlu M. κ-Carrageenan/Aloe vera-based bigels for sustained topical drug delivery: Design, characterization and melatonin release. Int J Biol Macromol 2026. doi:10.1016/j.ijbiomac.2026.151299. PMID 41794246 — vault. Tier 2 (formulation).
- S22Faria M, Bhanumathyamma D, Reji GM, Kuttiyatt ASB, Sivaprasad G, Viswanathan SP, et al. Diffusion-Controlled Release of Bromelain from κ-Carrageenan Nanocomposite Hydrogels Reinforced with Bio-Derived Nanofillers. Int J Mol Sci 2025;26(23):11438. doi:10.3390/ijms262311438. PMID 41373595 / PMC12691924 — vault. Tier 2 (formulation).
- S23Lewicka K, Smola-Dmochowska A, Dobrzyński P, Śmigiel-Gac N, Jelonek K, Musiał-Kulik M, et al. Microspheres Based on Blends of Chitosan Derivatives with Carrageenan as Vitamin Carriers in Cosmeceuticals. Polymers 2024;16(13):1815. doi:10.3390/polym16131815. PMID 39000669 / PMC11244320 — vault. Tier 2 (formulation; Franz cell).
- S24Georgiev MT, Simeonova SS, Konstantinov BG, Danov KD, Riley R, Woodall D. Conformational and rheological behavior of kappa carrageenan in glycerol: Effects of sodium salts and preparation temperature. Carbohydr Polym 2025. doi:10.1016/j.carbpol.2025.124095. PMID 40912799 — vault. Tier 2 (rheology).
- S25Sari MHM, Saccol CP, Custódio VN, da Rosa LS, da Costa JS, Fajardo AR, et al. Carrageenan-xanthan nanocomposite film with improved bioadhesion and permeation profile in human skin: A cutaneous-friendly platform for ketoprofen local delivery. Int J Biol Macromol 2024;265(Pt 1):130864. doi:10.1016/j.ijbiomac.2024.130864. PMID 38493820 — vault. Tier 2 (cast film/dressing; fetched, read, not relied on for any verdict).
- S27Co-formulation record: commercial cleanser INCI listing Chondrus Crispus Extract in Efficacy and safety of a new peeling formulated with a pool of PHAs… — vault. Tier 2 (unattributable; compatibility only).
- S28Co-formulation record: Efficacy Evaluation of a Topical Hyaluronic Acid Serum in Facial Photoaging (serum contains sodium carrageenan) — vault. Tier 2 (unattributable; compatibility only).
- S33Anti-Photoaging and Potential Skin Health Benefits of Seaweeds — Marine Drugs, 2021. PMID 33809936. Tier 2.
- S34Antiproliferative and Antioxidant Activities and Mycosporine-Like Amino Acid Profiles of Wild-Harvested and Cultivated Edible Canadian Marine Red Macroalgae — Molecules, 2016. PMID 26805798. Tier 2.
- S35Microspheres Based on Blends of Chitosan Derivatives with Carrageenan as Vitamin Carriers in Cosmeceuticals — Polymers, 2024. PMID 39000669. Tier 2.
- S36Diffusion-Controlled Release of Bromelain from κ-Carrageenan Nanocomposite Hydrogels Reinforced with Bio-Derived Nanofillers — International Journal of Molecular Sciences, 2025. PMID 41373595. Tier 2.
- S37The Role of Carrageenan in Inflammatory Bowel Diseases and Allergic Reactions: Where Do We Stand? — Nutrients, 2021. PMID 34684400. Tier 2. Oral/GI route throughout..
- S38Zinc Acetate/Carrageenan Gels Exhibit Potent Activity In Vivo against High-Dose Herpes Simplex Virus 2 Vaginal and Rectal Challenge — Antimicrobial Agents and Chemotherapy, 2012. PMID 22064530. Tier 2. Mucosal route; cited only for formulation-level metal binding and tolerance..
- S39Physicochemical Evaluation of Personal Care Products Developed with Chondrus crispus Fractions Processed by Ecofriendly Methodologies — Marine Drugs, 2022. PMID 36355018. Tier 2.



